他汀类药物对急性缺血性卒中患者尿激酶静脉溶栓临床疗效的影响OA北大核心CSTPCD
Effects of different doses of statins on clinical outcomes in patients with acute ischemic stroke who received intravenous urokinase thrombolysis
目的 探讨不同剂量他汀类药物对急性缺血性卒中(AIS)患者尿激酶静脉溶栓的临床疗效的影响.方法 基于一项前瞻性、多中心的大型研究——中国发病4.5 h内缺血性卒中的静脉溶栓登记研究(INTRECIS)数据库,回顾性分析经尿激酶静脉溶栓的898例AIS患者的临床资料.根据患者住院期间他汀类药物的用量分为不使用他汀组(132例)、常规剂量他汀组(591例)和强化剂量他汀组(175例).临床疗效评价指标包括14 d美国国立卫生研究院卒中量表(NIHSS…查看全部>>
Objective To investigate the effect of different doses of statins on the clinical efficacy and safety outcome of intravenous thrombolytic therapy of urokinase in patients with acute ischemic stroke(AIS).Methods Based on a large prospective,multicenter study,the Chinese Intravenous Thrombolysis Registry for AIS within 4.5 h of onset(INTRECIS)database,clinical data of 898 patients with urokinase intravenous thrombolysis for AIS were retrospectively analyzed.Ac…查看全部>>
王维姣;陈会生
解放军北部战区总医院神经内科,辽宁沈阳 110016解放军北部战区总医院神经内科,辽宁沈阳 110016
临床医学
他汀急性缺血性卒中尿激酶静脉溶栓预后
statinacute ischemic strokeurokinaseintravenous thrombolysisprognosis
《解放军医学杂志》 2024 (2)
152-158,7
This work was supported by the National Key Research and Development Program of China(2017YFC1308200) 国家重点研发计划(2017YFC1308200)
评论